Early introduction of peanut protein reduces allergy prevalence by approximately 80%, with efficacy diminishing as introduction is delayed. Appropriate prevention involves ingestion of ...

Oral immunotherapy (pOIT) significantly increases peanut challenge tolerance in children compared to avoidance, with 74% success in the pOIT group versus 11% in the avoidance group. The study ...

A low-dose peanut oral immunotherapy (OIT) protocol using parent-measured dosing can desensitize children aged 1-4 years with peanut allergy. The approach appears to be acceptably safe and may yield ...

Innovation is critical for success in the healthcare industry. A key step to that success is the evaluation of new therapies. Managers need to understand the commercial potential of ideas and invest ...

WASHINGTON — The Food and Drug Administration has approved the first treatment for children with peanut allergies. Allergy experts say Aimmune Therapeutics' Palforzia promises to lower the chances ...

New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut ...

Max Delbrück Center for Molecular Medicine in the Helmholtz Association Oral immunotherapy helps many children with peanut allergy – but for some, it can also trigger severe allergic reactions. In the ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection to peanut, finds a new study led by The Hospital for Sick Children (SickKids) and ...

Aimmune Therapeutics is teaming with Regeneron Pharmaceuticals in hopes of developing a cure for peanut allergies. Aimmune, based in Brisbane, California, specializes in food allergy treatments and ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The number of children diagnosed with peanut allergies in the U.S. has ...

A man with a life-threatening peanut allergy is living a near-normal life after taking part in a “life-changing” study which has offered hope to thousands of people. Richard Lassiter’s allergy is so ...